Cue Biopharma, Inc. (CUE)

SEC filing

Cue Biopharma, Inc.

CUE · CIK 1645460

4 · Oct 14, 2026 · Director, Chief Executive Officer Lin Shao-Lee sold 11.09K shares at $27.55/share ($305.5K)

Director, Chief Executive Officer Lin Shao-Lee sold 11.09K shares at $27.55/share ($305.5K)

xslF345X06/form4-10152026_011031.xml

xslF345X06/form4-10152026_011031.xmlSEC.gov

Graphics and non-inline formats (not embedded below).